Logo

Olink Bioscience Proseek Muliplex Neurology I96x96

Jan 27, 2016

Olink Bioscience has launched Proseek Mulitplex Neurology I96x96, a new human protein biomarker panel that targets research into neurobiology and neurological diseases. This latest development of the Proseek platform expands the library of unique biomarkers available to over 440 in total, and opens up Olink's innovative precision proteomics offering into a new and exciting field. The platform offers high-throughput multiplex immunoassays that measure 92 neurology-related proteins across 96 samples simultaneously using only one microliter of serum, plasma, cerebrospinal fluid, or almost any other type of biological sample.

Breaking News
The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.